Novosibirsk State Pedagogical University Bulletin, 2015, vol. 5, no. 1, pp. 80–87

Some aspects of infectious-allergic and toxic hepatitis and cirrhosis

Alimova L. A. 1 (Tashkent, Republic of Uzbekistan), Begmanov S. A. 1 (Tashkent, Republic of Uzbekistan), Nigmatov N. N. 1 (Tashkent, Republic of Uzbekistan), Abidova N. A. 1 (Tashkent, Republic of Uzbekistan)
1 Tashkent Pediatric Medical Institute, Tashkent, Uzbekistan

Experimental studies have been put on white rats and guinea pigs. Liver injury induced by two models hepatitis and liver cirrhosis, administration of hepatotoxic alkaloid – heliotrin and dysentery toxin, which is a dead, dried culture of Shiga bacilli.
When administered heliotrin and dysentery toxin observed severe damage liver tissue. On the background of circulatory disturbances expressed some of the animals met foci of necrosis of the liver lobules, often around the central veins, and significant lymphocytic infiltration hysteocitar that could be interpreted as a sign of delayed hypersensitivity.
Along with pathologic changes of the liver changes were observed T and B cell population, demonstrating functional changes characteristic of chronic hepatitis and liver cirrhosis. The most important factor in the genesis of liver cirrhosis – damage (necrosis) of hepatocytes caused by a direct toxic effect, as well as autoimmune processes. Sensitization of immune to the body's own tissues – an important factor in the pathogenesis and cirrhosis develops in patients with viral hepatitis B, C and D.


liver , autoimmune destruction, hepatitis, cirrhosis

For citation:
Alimova L. A., Begmanov S. A., Nigmatov N. N., Abidova N. A. Some aspects of infectious-allergic and toxic hepatitis and cirrhosis. Novosibirsk State Pedagogical University Bulletin, 2015, vol. 5, no. 1, pp. 80–87. DOI:

1. Rasmussen H. H., Fallingborg J. F., Mortensen P. B. et al. Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease. Scand. J. Gastroenterol. 1997, vol. 32 (6), pp. 604–610.
2. Bogomolov P. O. Shulpekova Y. O. Nonalcoholic fatty liver disease: hepatic steatosis and NASH. Clinical perspectives of gastroenterology, hepatology. 2004, no. 3, pp. 20–27. (In Russian)
3. Buyeverov A. O., Esanu V. S. Progress in the study of autoimmune hepatitis. Clinical perspectives of gastroenterology, hepatology. 2006, no. 4, pp. 7–15. (In Russian)
4. Grigoriev P. Ya. Fatty hepatosis: diagnosis, treatment and prevention of the text. Russ. Medical Journal. 2002. no. 1. pp. 30-31. (In Russian)
5. Dislipoproteidemy. The attending physician. 1999, no. 7. (In Russian) Available at:
6. Ivashkin, VT Diseases of the liver and biliary tract. Moscow, Medicine Publ., 2002. 370 p. (In Russian)
7. Ivashkin V. T., Komarov F. I., Rapoport S. I. Quick Guide to gastroenterology. Moscow, 2001,
458 p. (In Russian)
8. Kalinin A. V. Pathogenesis, clinical picture and treatment of alcoholic liver disease. Clinical Perspectives in Gastroenterology, Gepatology. 2001, no. 4, pp. 8–14. (In Russian)
9. Pintsani M. Evolution of hepatic fibrosis: from hepatitis to cirrhosis. Russ. Journal of Gastroenterology, Hepatology, Coloproctology. 2002. no. 5. pp. 4–9. (In Russian)
10. Skvortsova Z. P., Skvortsov V., Myazin R. G. et al. Hepatocellular insufficiency. Hepatology. 2003. no. 5. pp. 26–34. (In Russian)
11. Skrypnik I. N. Problem hepatotoxicity antimicrobials in terms of modern medicine. Health of Ukraine, 2009, no. 7, pp. 36–37. (In Ukrainian)
12. Sherlock S., Dooley J. Diseases of the liver and biliary tract. Praktical guide. Moscow, GEOTAR Medicine Publ., 1999, 864 p. (In Russian)

Date of the publication 04.02.2015